HemaSphere
(Jan 2022)
S123: SAFETY AND EFFICACY OF EARLY-START DEFERIPRONE IN INFANTS AND YOUNG CHILDREN WITH BETA-THALASSEMIA (START STUDY)
- M Elalfy,
- A El-Beshlawy,
- A Adly,
- F Ebeid,
- C Fradette,
- D Lee,
- N Temin,
- F Tricta,
- A Rozova,
- M Hamdy
Affiliations
- M Elalfy
- 1 Ain Shams University, Children’s Hospital, Cairo, EGYPT
- A El-Beshlawy
- 2 Cairo University, Pediatric Hospital, Cairo, EGYPT
- A Adly
- 1 Ain Shams University, Children’s Hospital, Cairo, EGYPT
- F Ebeid
- 1 Ain Shams University, Children’s Hospital, Cairo, EGYPT
- C Fradette
- 3 Chiesi Canada Corporation, Toronto, CANADA
- D Lee
- 3 Chiesi Canada Corporation, Toronto, CANADA
- N Temin
- 3 Chiesi Canada Corporation, Toronto, CANADA
- F Tricta
- 3 Chiesi Canada Corporation, Toronto, CANADA
- A Rozova
- 3 Chiesi Canada Corporation, Toronto, CANADA
- M Hamdy
- 4 Cairo University, Research Center, Cairo, EGYPT
- DOI
-
https://doi.org/10.1097/01.HS9.0000821460.57070.77
- Journal volume & issue
-
Vol. 6
pp.
12
– 13
WeChat QR code